Astigmatism Market Multiply Relentlessly; Asserts MRFR Unleashing Industry Forecast Up To 2022 :

Pune, India, February, 2018/MRFR Press Release/- Market Research Future published a Half-Cooked research report on “Astigmatism Market Research Report - Forecast till 2022”  – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.

 Market Overview:

Novartis AG (Switzerland), SeaVision USA (U.S.), Johnson & Johnson Services, Inc. (U.S.), Bausch & Lomb Incorporated (U.S.), CooperVision, Inc. (U.S.), Orion Vision Group (Georgia) are some of the leading players at the cutting edge of the competition in the market of astigmatism, globally.

Astigmatism is the situation in which patient suffered with blurred vision. It is a refractive error condition in which eyes not able to focus light evenly onto the retina. Normally astigmatism is occurring with condition like myopia and hyperopia, these both condition causes refractive errors because they affect how the eyes bend or "refract" light. It can be diagnosed by eye exam, and treatment depend upon the condition of astigmatism. There are two treatments are available for the common levels of astigmatism that are corrective lenses and refractive surgery. According to American Academy of Ophthalmology, in the United States 1 in 3 people may suffer with astigmatism and it may occur in combination with near- or farsightedness. Also, according to a report published by the Centers for Disease Control and Prevention in 2015, Around 11 million population of Americas of age 12 years and above improve their vision through proper refractive correction and more than 3.3 million Americans aged 40 years and older are either legally blind or are with low vision.

Access Report Deatails @ https://www.marketresearchfuture.com/reports/astigmatism-market-1734

Global Astigmatism Market – Overview

The global astigmatism market is showing the significant growth; mainly due to increase in the ageing population, eye injury, eye disease, and surgery. Companies are showing much interest toward the astigmatism market, as they feel there are huge opportunities and gaps between the market demand and supply of effective treatments. Thus, companies are showing more interest in research and development activities for introducing best treatment that meets the requirement of market. The development has been made by Novartis AG in 2017, Alcon is the division of Novartis and consider as a global leader in eye care, introduce AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery. Also, in 2018, Johnson & Johnson Vision announced the launch of expanded parameters for 1-DAY ACUVUE MOIST Brand Contact Lenses for astigmatism in the United States. These inventions help companies to meet the requirement of the market and maximize the profit share across the globe. Moreover, in 2017, Bausch & Lomb Incorporated division of Valeant Pharmaceuticals International, Inc. introduce Biotrue ONEday for Astigmatism daily disposable contact lenses in 20 countries of Europe. Novartis AG and Johnson & Johnson are trying to feel the gap along with market players such as SeaVision USA, Bausch & Lomb Incorporated, CooperVision, Inc., Orion Vision Group.

Global Astigmatism Market   - Regional Analysis

The market of astigmatism is much higher in the Americas region. There are several factors for tremendous growth of the astigmatism market in this region such as growing ageing population, presence of major market players, and increasing awareness about astigmatism. According to reports published by the Centers for Disease Control and Prevention in 2015, Around 1.8 million Americans aged 40 years and above are affected by AMD and an additional 7.3 million with large drusen are at substantial risk of developing AMD.

Europe is also considering the huge market for astigmatism players, owing to present of the huge ageing population. Moreover, the population within the reason are more aware about the healthcare in comparison to another region like Asia Pacific and The Middle East and Africa.

Asia Pacific and the Middle East and Africa region are considering the big opportunity for the market players owing to the presence of the high patient population. Whereas country like India and china of Asia Pacific region are considering fastest growing region owing to the presence of active government towards health care. These countries are open to adopt new treatment from developing countries in order to improve the quality of life for their citizen. Japan is a well-developed country and have well established healthcare system and technology, whereas developing countries are still focusing on new technology, which lead to increase in the demand for various astigmatism treatment. Most of the countries of these regions such as India and China are investing more into research and development activity for introducing better treatment at nominal price.